Resources & FAQs

Educational materials about umbilical cord stem cell science, exosome research, and answers to frequently asked questions.

Educational Overview

Comprehensive content for healthcare professionals, researchers, and individuals seeking to understand regenerative science.

What Are Mesenchymal Stem Cells?

Mesenchymal stem cells (MSCs) are multipotent stromal cells found in various tissues including bone marrow, adipose tissue, and umbilical cord tissue. They possess the ability to self-renew and differentiate into multiple cell lineages including osteoblasts, chondrocytes, and adipocytes. Human umbilical cord-derived MSCs (hUC-MSCs) are particularly noteworthy for their high proliferative capacity, low immunogenicity, and ease of collection without invasive procedures.

Understanding Immune Privilege

Immune privilege refers to the ability of certain cells or tissues to evade recognition and destruction by the immune system. hUC-MSCs exhibit immune privilege through low expression of MHC class I molecules and the absence of MHC class II molecules and co-stimulatory molecules (CD80, CD86). This allows them to be used in allogeneic (donor-to-recipient) applications with reduced risk of immune rejection.

Exosomes: Cell-Free Biologics

Exosomes are small extracellular vesicles (30–150 nm) released by cells, including MSCs, that carry a cargo of proteins, lipids, mRNAs, and microRNAs. MSC-derived exosomes facilitate intercellular communication and can modulate recipient cell behavior. They represent a cell-free approach with advantages including lower immunogenicity, no risk of tumorigenesis, easier storage and handling, and the ability to cross biological barriers.

Paracrine Mechanisms Explained

Rather than integrating into tissues and directly replacing damaged cells, MSCs primarily exert their effects through paracrine signaling—the secretion of bioactive molecules that influence neighboring cells. This secretome includes growth factors (VEGF, HGF, IGF-1), anti-inflammatory cytokines (IL-10, TGF-β), chemokines, and extracellular vesicles. MSCs do not transfer their DNA to recipient cells.

Clinical Research Standards

Clinical research with hUC-MSCs follows rigorous protocols including Institutional Review Board (IRB) approval, informed consent procedures, Good Manufacturing Practice (GMP) compliance, and systematic safety monitoring. Studies typically employ randomized, double-blind, placebo-controlled designs with dose-escalation phases.

FDA Regulatory Framework

In the United States, stem cell products are regulated by the FDA under the Public Health Service Act (Section 351) and 21 CFR Part 1271. Products that are “more than minimally manipulated” or used for non-homologous purposes require an Investigational New Drug (IND) application. Our laboratory adheres to all applicable FDA guidelines, cGMP standards, and regulatory requirements.

Key Takeaway: hUC-MSCs work primarily through paracrine signaling—not by replacing damaged cells directly. They secrete bioactive molecules that modulate inflammation, support tissue homeostasis, and promote natural regenerative processes. No DNA is transferred, and cell survival is transient.

Frequently Asked Questions

Have more questions? Our team is ready to help.

Disclaimer: The information on this page is for educational purposes only and is not intended as medical advice. Consult a qualified healthcare professional before making health-related decisions. These statements have not been evaluated by the Food and Drug Administration.